Overview
What Is the Wolverine Stack (BPC-157 + TB-500)?
The Wolverine Stack is the informal name for a peptide protocol that combines two compounds studied for their roles in tissue repair and recovery: BPC-157 and TB-500. The nickname nods to accelerated healing, and the pairing has become one of the most talked-about recovery stacks in the longevity and performance world.
The idea behind the stack is that the two peptides may work on complementary pathways. BPC-157 is a synthetic peptide derived from a protein found in gastric juice, and TB-500 is a synthetic version of a region of thymosin beta-4, a protein involved in cell migration and repair. Together they are explored, under medical supervision, to support recovery from soft-tissue strain and the wear-and-tear of active life. This page is about using the two together; if you are deciding between them, see BPC-157 vs TB-500.
It is important to be clear from the outset: BPC-157 and TB-500 are investigational peptides that have never been FDA-approved for any use, and this article is educational rather than medical advice. Whether either compound is appropriate for you is a decision that belongs with a qualified provider who knows your health history. At Protocol Health in Scarsdale, NY, any peptide protocol is physician-led, individualized, and often lab-informed.
Explore the Wolverine Stack protocolQuick Answer
What Does the Wolverine Stack Do, in Short?
The Wolverine Stack pairs BPC-157 and TB-500 in a protocol intended to support the body's natural recovery and tissue-repair processes. Active adults and clinicians explore it in the context of musculoskeletal recovery, soft-tissue strain, and general resilience.
Research on both peptides is largely preclinical, so responses can vary from person to person and nothing is guaranteed. When used, the compounds are prescribed and supervised by a physician, with dosing and duration individualized. If you are weighing it, the right next step is a consultation, not a self-directed experiment.
The Science
How Does the Wolverine Stack Work?
The Wolverine Stack works by pairing two peptides that are thought to act on different parts of the recovery cascade. BPC-157 (sometimes called pentadecapeptide, a 15-amino-acid chain) has been studied in animal models for its apparent effects on angiogenesis, the formation of new blood vessels that carry nutrients to healing tissue. Research suggests it may also interact with growth-factor pathways relevant to tendon, ligament, and gut tissue. Much of this evidence is preclinical, and human data remains limited.
TB-500 is a synthetic fragment modeled on thymosin beta-4, a naturally occurring peptide released by platelets, macrophages and many other cells after injury. Thymosin beta-4 binds actin, promotes cell migration, including the movement of progenitor cells that form new blood vessels, and has been associated with less scar formation in wounds (Goldstein et al., Expert Opinion on Biological Therapy, 2012). Most of that work concerns the full thymosin beta-4 protein; TB-500 itself has been studied far less.
The rationale for pairing them is that they are thought to act on different parts of the recovery cascade: BPC-157 more locally on the vascular and connective-tissue side, TB-500 more systemically on cellular migration and remodeling. Providers use this complementary logic to design a protocol, though mechanisms observed in the lab do not automatically translate to predictable outcomes in people.
Benefits
What Are the Potential Benefits People Look For?
The potential benefits people look for in the Wolverine Stack center on recovery. Reported reasons for interest include support for soft-tissue and musculoskeletal recovery, a smoother return to training after strain, and general resilience for a physically demanding lifestyle. These reflect how the stack is used and studied, not promised results.
Because BPC-157 has been studied in the context of gut and connective tissue, some people also explore it as part of a broader recovery and wellness picture. TB-500's association with tissue remodeling is what draws interest from athletes and active adults managing the cumulative toll of training.
It is honest to say the human evidence base is still developing. Many of the effects discussed online come from animal studies or anecdote, which is exactly why physician supervision matters. A provider can help you separate reasonable expectations from hype and decide whether a protocol fits your goals. For people whose real issue is broader, our pain and injury recovery program looks at the whole picture.
The Evidence
Does the Wolverine Stack Work? The Human Evidence, Counted
Nobody knows yet whether the Wolverine Stack works, because the human evidence, once counted, is a handful of uncontrolled cases and the stack has barely been studied in people. The evidence is easiest to judge when it is counted rather than summarised.
| Evidence | What it found | What it cannot tell you |
|---|---|---|
| 2025 systematic review of BPC-157 in sports medicine | 36 studies: 35 preclinical, 1 clinical. Better tendon, ligament, muscle and bone healing in animal models | Whether the same happens in people |
| Retrospective chart review, knee pain (2021) | 16 patients surveyed by phone; 11 of 12 given BPC-157 alone and 3 of 4 given BPC-157 plus thymosin beta-4 reported significant relief | No control group, no validated outcome measures, mixed causes of knee pain |
| IV safety pilot (2025) | 2 adults; no measurable effect on heart, liver, kidney, thyroid or glucose markers and no side effects | Anything about effectiveness, or safety in a larger group |
The 2025 systematic review in the HSS Journal found 544 articles on BPC-157 published between 1993 and 2024, of which 36 met its criteria; 35 were preclinical. In animal models BPC-157 improved functional, structural and biomechanical outcomes in muscle, tendon, ligament and bone injuries, appeared to reduce inflammatory cytokines and enhance pathways involved in angiogenesis. The authors found no clinical safety data in humans and warned that adverse effects are possible from unregulated manufacturing and contamination (Vasireddi et al., HSS Journal, 2025).
The only human data on the actual Wolverine combination is four patients in a 2021 retrospective review from a Florida clinic, three of whom reported significant knee pain relief after an injection of BPC-157 plus thymosin beta-4 (Lee & Padgett, Alternative Therapies in Health and Medicine, 2021). The 2025 systematic review summarized the same chart review more strictly: 7 of the 12 BPC-157-only patients reported relief lasting more than six months. That is a reason to study the stack properly, not proof that it works.
Candidacy
Who Is the Wolverine Stack For, and Who Should Avoid It?
The Wolverine Stack tends to attract active adults, weekend athletes, and people focused on longevity who are frustrated by slow recovery; people who are pregnant or breastfeeding should generally avoid it. Candidacy is always determined case-by-case by a provider who reviews your medical history, current medications, training load, and goals, often alongside baseline labs.
Peptide protocols are generally not appropriate for people who are pregnant or breastfeeding, and anyone with a history of cancer or significant medical conditions needs a careful, individualized conversation before considering compounds that influence cell growth and repair. This is not a decision to make from a forum post.
Candidacy can be assessed in person at our Scarsdale clinic and by telehealth in New York, New Jersey, Connecticut, Florida and California. The starting point is a consultation and, where indicated, lab work, so any recommendation is grounded in your actual physiology rather than a one-size-fits-all template.
Safety
Is the Wolverine Stack Safe? Side Effects to Know
The Wolverine Stack's safety in people is not yet established, and its side effects are known only from anecdote. Safety is the part of this conversation that deserves the most honesty. BPC-157 and TB-500 have never been FDA-approved for any use, so prescribing them is unapproved use, not off-label use. They are best approached only under medical supervision with pharmacy-sourced compounds and appropriate monitoring.
Two further points rarely appear on vendor pages. Both peptides are on the World Anti-Doping Agency's prohibited list, so competitive athletes should check their organization's anti-doping rules before considering either. And the only published human safety study of intravenous BPC-157 involved two people (Lee & Burgess, 2025), which is why monitoring is not optional.
Users report irritation at the injection site, lightheadedness or temporary fatigue, but those reports are anecdotal. The 2025 systematic review found no clinical safety data for BPC-157, and the FDA says it has not identified any human exposure data for TB-500; it has flagged both, when compounded, for possible immune reactions and peptide-related impurities (FDA). Quality and purity of the compound matter a great deal, which is one reason self-sourcing peptides online is risky.
Because these peptides interact with growth and repair pathways, a thorough medical review, including cancer history and current conditions, is essential before starting. A physician can weigh potential benefits against unknowns for your specific situation and monitor you along the way. That supervision is the single most important safety feature of any peptide protocol.
Dosage
Wolverine Stack Dosage: Why the Charts Online Are Guesswork
There is no validated wolverine stack dosage chart, because no validated human dose exists for either peptide. No controlled trial has compared doses of BPC-157 or TB-500 in people, alone or together.
Most of the numbers circulating online are extrapolated from rodent studies, which dose by body weight, or copied between vendor sites. The 2025 systematic review also found that BPC-157 has a half-life of under 30 minutes and is cleared by the kidneys, which makes simple per-day charts even harder to justify.
That is why Protocol Health does not publish a Wolverine Stack dosage guide. Where a physician judges a peptide protocol appropriate, the amount, schedule and cycle length are set individually, sourced from a licensed pharmacy, and reviewed at follow-up.
The Process
What to Expect When Starting a Peptide Protocol
When starting a peptide protocol, expect to begin with a consultation where a provider reviews your history, goals, and any prior injuries or training patterns. Where appropriate, baseline lab work helps establish a clear starting point and rule out concerns before any protocol is considered.
If a peptide protocol is deemed appropriate, dosing, duration, and administration are individualized. BPC-157 and TB-500 are typically administered by subcutaneous injection, and your provider will explain technique, scheduling, and what to watch for. Protocols are usually run in defined cycles rather than open-endedly.
Follow-up matters. You and your provider track how you respond, adjust as needed, and reassess whether to continue. This iterative, monitored approach is what separates a supervised clinical protocol from a do-it-yourself experiment.
Our Approach
The Protocol Health Approach to Peptides
Protocol Health is a family-owned, physician-led clinic in Scarsdale, NY, seeing patients in person at our Scarsdale clinic and by telehealth in New York, New Jersey, Connecticut, Florida and California. Our approach to peptides is deliberately conservative: education first, individualized assessment, real lab data where it helps, and ongoing supervision by a clinical team.
We treat the Wolverine Stack as one option within a broader recovery and longevity toolkit, not a miracle. For some people the right answer is a peptide protocol; for others it is addressing sleep, hormones, training load, or an underlying issue that recovery peptides will not fix. That clinical honesty is the point.
The bottom line on the Wolverine Stack: the animal data for each peptide is consistent, the human data on the combination is four patients, and neither peptide is FDA-approved. The Protocol Health Wolverine Stack is prescribed only after a consultation. If you are curious whether BPC-157, TB-500, or a combined protocol fits your goals, the next step is a conversation with a provider who can look at the whole picture and give you a straight, individualized answer.
FAQ
Frequently Asked Questions
What is the Wolverine Stack?
The Wolverine Stack is an informal name for a peptide protocol that combines BPC-157 and TB-500, two investigational peptides studied for their roles in tissue repair and recovery. When used, it is done under physician supervision, most often by active adults focused on recovery and resilience. The nickname refers to the goal of supporting the body's natural healing processes, not a guaranteed outcome.
Are BPC-157 and TB-500 FDA-approved?
No. Neither BPC-157 nor TB-500 is an FDA-approved drug. They have never been FDA-approved for any use, which is exactly why they should only be considered under the supervision of a qualified physician using quality-controlled sources and appropriate monitoring, rather than self-sourced online.
Is there a standard Wolverine Stack dosage?
No. No controlled human trial has established a dose for BPC-157 or TB-500, alone or combined, so dosage charts online are extrapolated from animal studies or copied between vendors. When a physician prescribes a peptide protocol, the amount and cycle are individualized and monitored.
Is there human research on the Wolverine Stack?
Very little. A 2025 systematic review found 35 preclinical studies of BPC-157 and one clinical report. The only human data on the combined stack is four patients in a 2021 retrospective knee-pain review, three of whom reported relief. It is promising but unproven.
How is the Wolverine Stack administered?
BPC-157 and TB-500 are typically given by subcutaneous injection, with dosing and cycle length individualized by your provider. Your clinical team will walk you through technique, timing, and what to monitor. Protocols are generally run in defined cycles rather than continuously.
What are the side effects of the Wolverine Stack?
Human safety data are essentially absent: there is no clinical safety data for BPC-157 and no identified human exposure data for TB-500. Users report injection-site irritation, lightheadedness or temporary fatigue, but those reports are anecdotal. Anyone with a history of cancer or a significant medical condition should have a careful, individualized conversation with a physician before considering these peptides.
Who should not use the Wolverine Stack?
Peptide protocols are generally not appropriate for people who are pregnant or breastfeeding, and anyone with a cancer history or serious medical condition needs individualized medical review first. Candidacy is always determined case-by-case by a provider after reviewing your history and, where indicated, lab work.
Can I get the Wolverine Stack through telehealth?
Protocol Health sees patients in person at our Scarsdale clinic and by telehealth in New York, New Jersey, Connecticut, Florida and California. Whether a peptide protocol is appropriate is assessed during a consultation, so the first step is booking an assessment rather than ordering anything directly.
Explore
Related at Protocol Health
Explore the Wolverine Stack protocolThis article is educational and is not medical advice. It does not diagnose, prevent, treat or cure any condition. Talk with a licensed clinician about your own situation.